Robbinsville, NJ, United States of America

James A Milligan


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1990)
  • Robbinsville, NJ (US) (1991)

Company Filing History:


Years Active: 1990-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: James A. Milligan

Introduction: James A. Milligan is a prominent inventor based in Robbinsville, NJ, with a significant contribution to the field of pharmaceutical sciences. He holds a total of three patents, reflecting his innovative thinking and dedication to advancing medical treatments. His work primarily focuses on compounds that exhibit antifungal properties, showcasing his commitment to addressing critical health challenges.

Latest Patents: Milligan's latest patents include groundbreaking developments in antifungal therapies. His first patent is for "Novel HMG-CoA synthase inhibitors," where the compounds of formulas (I) and (II) are designed as HMG-CoA synthase inhibitors that exhibit antifungal activity. This innovation is a step towards providing effective treatment options for fungal infections. Additionally, his second patent involves "Novel anti-fungal compounds," which details a method of inhibiting fungal growth by utilizing an antifungal amount of a compound of formula (I). Both of these patents contribute to the growing body of knowledge in combating fungal diseases.

Career Highlights: James A. Milligan has built a notable career working at Merck & Company, Inc., a globally recognized leader in the pharmaceutical industry. His role involves research and development, where he focuses on discovering new medicinal compounds that improve patient outcomes. His patents underline his expertise and influence in the pharmaceutical field.

Collaborations: Throughout his career, Milligan has collaborated with esteemed colleagues Walter Rozdilsky and Janet C. Onishi. These partnerships have harnessed collective expertise to push the boundaries of innovation in antifungal research, leading to impactful discoveries that enhance therapeutic options available in the market.

Conclusion: In summary, James A. Milligan represents the spirit of innovation in the pharmaceutical industry. His work at Merck & Company, Inc. and his patents on antifungal compounds illustrate his dedication to developing solutions for health challenges faced by many. With each new invention, James continues to make a substantial impact on the fight against fungal infections, showcasing the importance of research and innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…